The Children’s Hospital of Philadelphia Research Institute’s own Philip R. Johnson, MD was consulted for a number of articles about an exciting new HIV vaccine study.
Monthly Archive: February 2015
According to new research, children born with a DNA abnormality on chromosome 16 already linked to neurodevelopmental problems show measurable delays in processing sound and language.
Winners chosen for the fall round of the CPCE’s Pilot Grant Program will focus on two projects that aim to have an impact on clinical decision-making.
The Philadelphia Pediatric Medical Device Consortium (PPDC) announced that it will provide seed grants of $25,000 each to three companies to transform their innovative ideas into commercial devices that benefit young patients.
Neuroscience researcher Hajime Takano, PhD, who works in Douglas Coulter, PhD’s, epilepsy research laboratory at The Children’s Hospital of Philadelphia, is especially interested in which specific neurons could be inciting the neural network.
Children’s Hospital immunogenetics experts developed a unique laboratory test to characterize the genes that encode human leukocyte antigen (HLA) molecules, which are complex proteins on cell surfaces that are essential to immune function.
Funded by the National Cancer Institute, the LEGACY study is unique in its focus on healthy, young girls and how their habits and development are related to breast health.
Scientists have identified four new genes associated with the severe food allergy eosinophilic esophagitis (EoE).
Christopher B. Forrest, MD, PhD, a CHOP pediatrician, recently received a two-year grant to develop PROMIS pediatric sleep health measures that will fill this gap and enable patients and their families to express exactly how health conditions and treatments affect their sleep.
While influenza vaccination is important for all children, it is critical that pediatric patients with cancer get a flu shot because their weakened immune systems leave them especially vulnerable to severe infections.